Gelonghui, April 9, 丨 Enhua Pharmaceutical (002262.SZ) held a performance briefing on April 8, 2024 to discuss “Why has the new drug NVX-408 not progressed?” The company replied that the company's new drug NVX-408 project is still in the pre-clinical research stage.
恩华药业(002262.SZ)：新药NVX-408项目尚处于临床前研究阶段
Enhua Pharmaceutical (002262.SZ): The new drug NVX-408 project is still in the pre-clinical research stage
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.